There are some risks associated with compounded tirzepatide (as well as similar drugs like compounded semaglutide), such as: Dosing errors resulting from incorrectly measuring the dose, which can lead to serious side effects from taking too much medicine (With Mounjaro, the dose is loaded into the prefilled pen, so it is unlikely you will inject an incorrect dose.) Ingredients, such as retatrutide, that are labeled for research purposes or not for human consumption and have been found in compounded products that are provided to patients Contaminated and non-sterile products, which can be dangerous Counterfeit drugs, that may contain the wrong drug, too much or too little of the drug, or no drug at allalong with illegal sales that do not require a prescription In addition to these risks, remember that compounded tirzepatide products have not been tested or FDA approved, so it is not known if the product you receive is safe, effective, and of high quality
But these kinds of studies are very good at generating new research questions like why would medication that helps people lose weight be associated with an increased risk of arthritis, as this study showed
This discrepancy [between studies] may be explained by unmeasured confounders, such as weight and body mass index factors associated with thyroid cancer that are notoriously challenging to capture accurately in large observational studies, the authors wrote
DPP-4 inhibitors can be used as monotherapy when metformin is contraindicated or not tolerated
Several animal experiments and clinical trials have demonstrated that GLP-1R agonists are more effective in treating or preventing obesity
Prim Care Diabetes
